SecBot SecBot

SOLV

Solventum Corp
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001964738 Healthcare & Medical Devices
$88.65 −0.43 (−0.48%)
Nov 16 4:00 PM ET · prev $89.08
Market cap
$15.1B
Large cap
Consensus
Buy
59% Buy or better · 22 analysts
Median target
$100.00
+13% · range $75.00–115.00
1 year
+16.4%
from $76.19 · Nov 17
30 days
+4.2%
from $85.05
52-week range
$62.49–92.44
−4% from high · low Apr 7
Avg volume 20D
1.28M
shares / day
Short interest
5.05M
≈3.0% of shares · +1.9%
Days to cover
4.6
at average volume
Insider net
$0
no open-market trades · since Mar 27
New fund stakes
5
Q2 2026 13F · 1 exit
Filing reports
9
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 1 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/4

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 27. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 48 added (5 new), 48 trimmed or exited. Largest new: Polar Capital Holdings $72.2M, Jane Street Group $51.4M.

  • AnalystsBULLISH

    13 of 22 rate it Buy or better. Median target $100.00 (+13%).

  • Short sellersSTEADY

    Short interest +1.9% to 5.05M shares. 4.6 days to cover, ≈3.0% of shares.

  • TrendUPTREND

    1% above its 50-day average.

Who's buying

13F· Q2 2026
5
new positions
1
exit
$203.8M
in new stakes
FundMoveSharesValue
DIMENSIONAL FUND ADVISORS LPDOUBLED1,817,658$140.2M
MILLENNIUM MANAGEMENT LLCDOUBLED1,199,940$92.6M
Polar Capital Holdings PlcNEW935,761$72.2M
JANE STREET GROUP, LLCNEW666,327$51.4M
Nuveen, LLCADD600,071$46.3M
D. E. Shaw & Co., Inc.DOUBLED526,392$40.6M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPTRIM469,316$36.2M
PFA Pension, ForsikringsaktieselskabNEW440,691$34.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

22 analysts
Buy 59% rate it Buy or better
Strong Buy6Buy7Hold8Sell1Strong Sell0
12-month targets · 13 analysts

Price is inside the target range. Median implies +13%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 6, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Nov 6, 2026Piper Sandler
REITERATE
REITERATEOverweight
Sep 14, 2026BTIG
REITERATE
REITERATEBuy
Aug 6, 2026UBS
MAINTAIN
MAINTAINBuy
Aug 6, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight
Aug 6, 2026Wedbush
MAINTAIN
MAINTAINOutperform

Washington

Corporate Lobbying

24 lobbying filings and 1 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 27
DateInsiderTypeValue
Sep 1, 2026
Hanson Bryan C
Chief Executive Officer
Sep 1, 2026
TAX W/H$2.4M
Sep 1, 2026
Hanson Bryan C
Chief Executive Officer
Sep 1, 2026
EXERCISE67,261 sh
Aug 17, 2026
Zieselman Neil Craig
SVP, Controller & CAO
Aug 17, 2026
AWARD6,911 sh
May 15, 2026
DeVore Susan D.
Director
May 15, 2026
AWARD3,300 sh
May 15, 2026
Wilson Darryl L.
Director
May 15, 2026
AWARD3,300 sh
May 15, 2026
Wendell Amy McBride
Director
May 15, 2026
AWARD3,300 sh
May 15, 2026
WEILAND JOHN H
Director
May 15, 2026
AWARD3,300 sh
May 15, 2026
MAY KAREN J
Director
May 15, 2026
AWARD3,300 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
SOLV trades disclosed by members of Congress, with disclosure delay.
3 members · 3 buys / 1 sells
DateMemberType AmountDisclosed
May 27, 2026 Ro KhannaDHouse Spouse account · SOLVENTUM CORP BUY $1K–$15K Jun 9, 2026 +13d
May 1, 2026 Ro KhannaDHouse Child account · SOLVENTUM CORP BUY $1K–$15K Jun 9, 2026 +39d
Mar 27, 2026 Alan ArmstrongRSenate Joint account · SOLVENTUM CORP BUY $1K–$15K Jul 21, 2026 +116d
May 3, 2024 Tommy TubervilleRSenate Joint account · SOLVENTUM CORP SELL $1K–$15K Aug 5, 2026 +824d

Short side

FINRA· Oct 30, 2026
5,047,939
shares short
+1.9%
vs prior settlement
4.6
days to cover
≈3.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 5, 2026 SEC
Solventum reported Q3 2026 adjusted EPS of $1.45, beating the $1.34 consensus, on revenue of $1.949B which was…
8-K · Impact 6/10
Nov 5, 2026 Earnings result
SOLV Q3 2026 Earnings: EPS $1.45 (+5.0% vs est)
Nov 4, 2026 SEC
Five institutional investors added $126.8M in net new Solventum Corp positions during Q3 2026, led by Dimensional Fund…
INST-CLUSTER · Impact 3/10
Oct 27, 2026 SEC
In Q2 2026, 48 institutional buyers accumulated $253.9M in Solventum Corp (SOLV) while 48 sellers reduced holdings by…
INST-CLUSTER · Impact 4/10
Sep 1, 2026 Insider
Hanson Bryan C surrendered for taxes 26,468 shares
Chief Executive Officer @ $90.95 ($2.4M)
Sep 1, 2026 Insider
Hanson Bryan C acquired via exercise 67,261 shares
Chief Executive Officer
Aug 17, 2026 Insider
Zieselman Neil Craig was granted 6,911 shares
SVP, Controller & CAO
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP · DOUBLED
1,817,658 shares ($140.2M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

9 filings · 1 bullish · 0 bearish · 3 mixed · 5 neutral
All SOLV filing & press-release reports (9)